Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (RACE) ultra-luxury sports car manufacturer at €6.7B revenue and 26.5% EBIT margin shipping 14,291 vehicles; competing with Lamborghini for F1-heritage prestige at €350K+ average selling prices.
Ferrari N.V. is a Maranello, Italy-based luxury sports car manufacturer — listed on NYSE (NYSE: RACE) and the Milan Stock Exchange (MIL: RACE) — producing limited-volume high-performance supercars, grand touring vehicles, and GT racing cars under the Ferrari brand since 1939. Founded by Enzo Ferrari and generating €6.7 billion in revenue in fiscal year 2024 with 14,291 vehicles shipped and a 26.5% adjusted EBIT margin, Ferrari represents one of the world's most profitable luxury goods businesses, commanding €350,000+ average selling prices for production vehicles and €3-5 million+ for limited-edition hypercars (LaFerrari, SF90 Stradale, Purosangue SUV).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.